Park N Chem Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 8.00 M
- Paid Up Capital ₹ 8.00 M
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 5.69 Cr
- Revenue Growth 33.78%
- Profit Growth 13.85%
- Ebitda -6.98%
- Net Worth 1.78%
- Total Assets 15.57%
About Park N Chem Pharmaceuticals
Park N Chem Pharmaceuticals Private Limited (PNCPPL) is a leading Private Limited Indian Non-Government Company incorporated in India on 01 July 2005 and has a history of 19 years and seven months. Its registered office is in Amritsar, Punjab.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 8.00 M and a paid-up capital of Rs 8.00 M.
The company currently has active open charges totaling ₹5.69 Cr.
Anil Seth and Kunal Seth serve as directors at the Company.
Company Details
-
LocationAmritsar, Punjab
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24230PB2005PTC028616
-
Company No.
028616
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
01 Jul 2005
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Chandigarh
Industry
Who are the key members and board of directors at Park N Chem Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Anil Seth
|
Director | 01-Jul-2005 | Current |
|
Kunal Seth
|
Director | 09-Apr-2011 | Current |
Financial Performance of Park N Chem Pharmaceuticals.
Park N Chem Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 33.78% increase. The company also saw a substantial improvement in profitability, with a 13.85% increase in profit. The company's net worth moved up by a moderate rise of 1.78%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Park N Chem Pharmaceuticals?
In 2022, Park N Chem Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹56.85 M
₹0
Charges Breakdown by Lending Institutions
- Bank Of India : 5.69 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Nov 2023 | Bank Of India | ₹2.70 M | Open |
| 06 Apr 2023 | Bank Of India | ₹4.00 M | Open |
| 06 Apr 2023 | Bank Of India | ₹3.21 M | Open |
| 06 Apr 2023 | Bank Of India | ₹0.98 M | Open |
| 06 Apr 2023 | Bank Of India | ₹1.00 M | Open |
How Many Employees Work at Park N Chem Pharmaceuticals?
Park N Chem Pharmaceuticals has a workforce of 25 employees as of Apr 02, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Park N Chem Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Park N Chem Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
